尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Hoffmann Rolf K, 董事. Director active across 1 company, notably Paratek Pharmaceuticals, Inc.. Aggregated, 3 reports have been logged. History available since 16 February 2022. The latest transaction was disclosed on 8 February 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Rolf K. Hoffmann is a Board Member at Paratek Pharmaceuticals, Inc. He brings expertise in corporate governance and pharmaceutical strategy. His role as a board member allows him to contribute to strategic decision-making and the direction of the company.